Head to head for first-timers
CoreAge Rx vs Zealthy
CoreAge Rx and Zealthy both offer GLP-1 telehealth, but they make different trade-offs on how gentle the start is, honest pricing, real support and access. Here they are side by side on the Mama-Match Score — our first-timer rubric.
CoreAge Rx
Higher scoreRank #1 for first-timers · Grade A
Mama-Match
Best for: Moms who want a clear, honest first step — a real clinician instead of a questionnaire, a flat price, and the freedom to pause when life needs you to.
Visit CoreAge RxZealthy
Rank #293 for first-timers · Grade C
Mama-Match
Best for: Nothing, while the federal case is open. It stays on the board for transparency, not as a suggestion.
Visit ZealthyThe verdict for a first step
CoreAge Rx edges out Zealthy on the Mama-Match Score, 94 to 39 (A vs C). Moms who want a clear, honest first step — a real clinician instead of a questionnaire, a flat price, and the freedom to pause when life needs you to.
Zealthy is still a genuine option — ⛔ FDA warning letter #716501 (Sept. 2025) and, in April 2026, the FTC and DOJ moved to seize the company and freeze its assets. Read that first. Weigh the six first-timer factors below against your own priorities.
Side by side on all six factors
Both providers judged on the same first-timer rubric — the higher side on each factor is marked. See the methodology.
Price, access and features
| Detail | CoreAge Rx | Zealthy |
|---|---|---|
| Mama-Match Score | 94/100 · A | 39/100 · C |
| Overall rank | #1 | #293 |
| Semaglutide | $99/mo | $135/mo |
| Tirzepatide | $149/mo | $225/mo |
| Coverage | All 50 states | Most states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Mama-Match
CoreAge Rx
Rank #1 · Grade A
What we like
- One flat monthly price, with no teaser rate that jumps after the first month — you know the number before you commit
- A clinician reads your history and will genuinely talk timing with you if you're postpartum, breastfeeding, or trying to conceive
- Semaglutide and tirzepatide in one account, so you and a clinician can choose — and switch — without starting over
The caveats
- Not the rock-bottom teaser price — a couple of marketplaces dangle a lower first-month number
- Compounded medication only, not FDA-approved brand-name Ozempic or Wegovy
- A general metabolic program, not a dedicated OB-GYN or hormone consult
Mama-Match
Zealthy
Rank #293 · Grade C
What we like
- Low, published monthly pricing for semaglutide and tirzepatide
- Coverage in most states with a fast, low-friction signup
- Straightforward compounded model — you see the cost before you commit
The caveats
- ⛔ FDA warning letter #716501, dated September 9, 2025, to FitRX, LLC dba Zealthy, for unlawful sale of unapproved and misbranded drugs over the internet — the letter names its own site
- April 2026: the FTC and DOJ asked a federal court to place Zealthy in receivership and freeze its assets, alleging deceptive disclosures, obstructive cancellation and review manipulation
- The same complaint alleges misuse of clinicians' NPI numbers to issue prescriptions without their knowledge or consent — the government's words are that Zealthy is "actively deceiving telehealth patients, endangering their safety, and raiding their bank accounts". These are allegations, not findings; the case is ongoing
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Mama-Match Score. Prices, states and verification reflect what each provider disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the methodology. Prices change — confirm them on each provider’s site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and Zealthy with the other providers we review for women.
- CoreAge Rx vs Eden
- CoreAge Rx vs Pallas Health
- CoreAge Rx vs Trimi Health
- Zealthy vs Eden
- Zealthy vs Sesame
- Zealthy vs Hers
Or browse the full comparison hub.